Counter-Balanced Immune Response Against Cas9-Mediated Epigenetic Modulation Induces Durable Therapeutic Efficacy
Time: 12:00 pm
day: Conference Day Two
Details:
- Exploring dosage for gene editing
- Examining the efficacy of gene editing
- Reducing AAV immunogenicity
